-MRI has proven to be an important tool for the evaluation of patients suspected of having HCM. Cardiac MR imaging is useful for making a diagnosis and identifying the phenotypes of HCM , can also contribute to risk stratification because of its accurate measurement of LVH, detection of “high-risk” phenotypes, and identification of myocardial fibrosis

-An appropriate study protocol aimed at revealing the keys to the disease

 and a  deep understanding of the pathophysiology of the disease is essential to understand the role of MRI paper in HCM

-A practical updated management guide by CMRI, including  technical, clinical and pathophysiological and risk startification aspects, allows a faster and more reliable and accurate diagnosis and a better approach to the risk stratification of SCD.